Interference in AR/FlnA complex assembly by new molecules, such as AR-derived peptides (11), may represent a promising approach to the therapy of PCa by specifically modulating signaling pathways activated by AR in stromal cells. Here, FLNA is linked to posterior cortical atrophy.